Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.45), $0.07 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $133.78 million versus the consensus estimate of $129.31 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.